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ABSTRACT Epidermolysis bullosa simplex (EBS) is a
group of autosomal dominant skin diseases characterized by
blistering, due to mechanical stress-induced degeneration of
basal epidermal cells. It is now well-established that the three
major subtypes of EBS are genetic disorders of the basal
epidermal keratins, keratin 5 (K5) and keratin 14 (K14). Here
we show that a rare subtype, referred to as EBS with mottled
pigmentation (MP), is also a disorder of these keratins.
Affected members of two seemingly unrelated families with
EBS-MP had a C to T point mutation in the second base
position of codon 24 of one of two KS alleles, leading to a
Pro:Leu mutation. This mutation was not present in unaf-
fected members nor in 100 alleles from normal individuals.
Linkage analyses mapped the defect to this type H keratin gene
(peak logarithm of odds score at 4) = 0 of 3.9), which is located
on chromosome 12q11-q13. This provides strong evidence that
this mutation is responsible for the EBS-MP phenotype. Only
conserved between K5 and K6, and not among any of the other
type H keratins, Pro-24 is in the nonhelical head domain of K5,
and only mildly perturbs the length of 10-nm keratin filaments
assembled in vitro. However, this part of the K5 head domain is
likely to protrude on the filament surface, perhaps leading to
additional aberrations in intermediate filament architecture
and/or in melanosome distribution that are seen ultrastructur-
ally in patients with the mutation.
Epidermolysis bullosa simplex (EBS) has been subdivided into
three major types (1-3). (i) EBS Dowling-Meara (EBS-DM) is
the most severe type, typified by blistering over whole body
regions and keratin filament clumping and cytolysis in basal
cells. (ii) EBS Kobner (EBS-K) is also characterized by gen-
eralized blistering and basal cell cytolysis, but with fewer
abnormalities in basal cell keratin networks. (iii) EBS Weber-
Cockayne (EBS-WC) is the mildest form, with blistering
concentrated primarily in palmar and plantar regions, and very
minor keratin filament perturbations. An unusual and rare
form of EBS with generalized blistering and hyper- and
hypopigmented spots over the body surface was first reported
by Fischer and Gedde-Dahl (4). The unifying feature of all of
these EBS subtypes is basal cell cytolysis, with a largely normal
differentiation process in the suprabasal layers.
Anton-Lamprecht initially suggested that EBS-DM might
be a disorder of keratin (1), and demonstrated that keratin
filament clumping preceded cell cytolysis. Experimental sup-
port for this hypothesis was provided years later, when trans-
genic mice expressing a mutant keratin 14 (K14) gene dis-
played abnormalities bearing a striking resemblance to
EBS-DM (5). Since K14 (type I) and its partner K5 (type II)
is the keratin pair specifically expressed in the basal layer of
epidermis (6), this led to the prediction that mutations in either
one of these two keratins might be the underlying cause of EBS
in humans. Subsequent analyses of human patients with
EBS-DM or EBS-K led to the discovery of point mutations in
either the KS or K14 genes (7-9). Later studies on EBS-WC
added this subtype to the list of genetic disorders of these basal
keratins (10-12).
The classification according to subtype can also be made
genetically and according to the ability of different K14 and K5
mutations to affect their assembly into 10 nm intermediate
filaments (13, 14). Patients with EBS-DM frequently have
point mutations located within 10 amino acid residues at either
end of the central, a-helical rod domain involved in coiled-coil
heterodimerization between type I and type II keratin
polypeptide chains (Fig. 1A; refs. 7, 9, 18-20). EBS-K muta-
tions are typically more internal within the rod (8, 21, 22). In
contrast, EBS-WC mutations seem to localize to two specific
regions: (i) an I161S hot spot found in one of two KS alleles
of a number of apparently unrelated cases of EBS-WC (10, 23)
and (ii) a region within a nonhelical linker segment (L1-2)
located in the middle of the a-helical rod segment of the K14
and KS polypeptides (11, 12, 22).
These mutations affect intermediate filament assembly in
different ways. The EBS-DM mutations affect filament elon-
gation (7, 13, 14). The elongation process is thought to depend
upon the head-to-tail alignment of heterodimers in a linear
array (ref. 24; Fig. 1B). The importance of the rod ends is likely
due to an interaction between the amino end of one het-
erodimer and the carboxy end of a connecting heterodimer
(26, 27). In contrast, the L1-2 linker mutations in EBS-WC
seem to have a greater effect on lateral associations, yielding
filaments in vitro that are longer, but more unraveled, thanDM
mutant filaments (11). It has been postulated that the linker
may be involved in aligning antiparallel arrays of dimers in a
half-staggered position relative to each chain (24-28). Of the
head and tail segments of KS and K14, all but the portion of the
KS head domain adjacent to the rod domain could be deleted
without grossly perturbing 10 nm filament assembly in vitro (29).
TIhe genetic bases for the rarer subtypes of EBS, including
EBS with mottled pigmentation (EBS-MP), have not yet been
determined. EBS-MP is unusual in that patients have skin
blistering similar to that of EBS, but in addition, they have
striking MP (4, 30-33). In the initial Swedish Epidermolysis
Bullosa simplex (SEB1) family described with this syndrome,
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FIG. 1. Mutations in EBS and model of keratin filament assembly.
(A) Stick Fig. depicts the secondary structure predicted for keratin (15,
16). Open boxes denote the four a-helices (1A, 1B, 2A, and 2B)
constituting the coiled-coil rod domain. Lines between these segments
are three short nonhelical linker segments (Li, Ll-2, and L2, respec-
tively). Hatched boxes denote highly conserved ends of the rod. Two
black boxes denote the Hi portion of the nonhelical head domain (17)
and the carboxyl-terminal tail segment. Remainder of the head
domain is shown in white. Point mutations found thus far in patients
with EBS are indicated by vertical bars. Top, K5 mutations; bottom,
K14 mutations. Mutations are: solid circles, EBS-WC; open circles,
EBS-K; triangles, EBS-DM; *, hot spots where mutations have been
found repeatedly. Vertical bar marked 24 is discussed in text. N, amino
terminus; C, carboxyl terminus. (Reprinted with permission from
Blackwell Publishers.) (B) Putative arrangement of heterodimer ker-
atin subunits in the 10 nm keratin filament. Model is adapted from that
previously described (24). Arrow within each heterodimer indicates
direction of the two parallely aligned polypeptides, from base (N
terminus) to tip (C terminus). Hatched boxes denote highly conserved
ends of the rod, which are predicted to overlap in the arrangement of
linear arrays (26, 27). Small black box denotes region of Ll-2 linker
where EBS mutations are clustered (see A). [Reprinted with permis-
sion from The Rockefeller University Press (25).]
affected members had pigmented spots 2-5 mm in diameter
that formed a mosaic pigmentation pattern over the body
surface (4). The pigmentation anomalies in EBS-MP are
contrasted from many other genetic disorders in that inflam-
mation is not generally involved. It has been postulated that the
pattern of MP might be dependent upon autosomal inactiva-
tion of an ectodermal gene, perhaps one involved in the uptake
of melanosomes by epidermal cells (4). Melanocytes them-
selves, and melanosome production, appear normal (33).
In this EBS-MP family now spanning four generations, all 12
affected members showed clinical features of both EBS and
MP. Whether the disorder represents a single mutant gene or
mutations in two very closely linked genes has remained
unanswered, and the etiology of the disorder remains un-
known. Previously, we noted that the distribution of mitochon-
dria is aberrant in some EBS cases (11, 34). In this context, we
were intrigued by the possibility that certain keratin disorders
might affect organelle distribution, perhaps including mela-
nosomes. To explore this possibility further and to determine
the underlying genetic basis of EBS-MP, we used ultrastruc-
ture, sequence, and functional analyses on two different fam-
ilies with this disorder.
MATERIALS AND METHODS
Biopsies and Blood Samples. One clinically affected mem-
ber of family EBS 44 (EBS 44-3) and three of family SEB1
(SEBB-41, 1-42, and 1-44) donated skin biopsies for ultrastruc-
tural studies. Biopsies were taken from a nonblistered area of
hypo- and hyperpigmented skin. Blood samples (5 ml) were
taken for isolation of genomic DNA from four family members
of EBS 44 and from 18 family members of SEB1. From the
deceased SEB1-22, frozen fibroblasts were recovered for DNA
isolation.
DNA Sequence Analysis. Four different pairs of oligonucle-
otide primers were selected to encompass the entire coding
sequence of the K5 gene (35, 37), and polymerase chain
reaction (PCR) amplification was performed to amplify KS
sequences from patients EBS 44-3 and SEB1-22. DNAs were
then resolved by gel electrophoresis, and fragments were
subcloned into the pCRII plasmid vector (TA Cloning System,
Invitrogen). Twelve to 13 clones were pooled and purified
using the Qiagen (Chatsworth, CA) Plasmid Maxi Kit. DNAs
were sequenced using a standard dideoxy protocol (Sequenase
2.0, Amersham). To confirm the presence or absence of the
identified mutation in the remaining family members, we
amplified the appropriate region and sequenced the PCR
product using a CircumVent Thermal Cycle dideoxy Sequenc-
ing Kit (New England Biolabs).
PCR Amplification of Specific Allele Analysis of the Mu-
tation. PCR amplification of specific alleles was used to check
for the absence of the EBS-MP mutation in unrelated wild-
type individuals. Primers used were: wild-type allele, 5'-GC-
CTCTGCCATCACCCC-3'; mutant allele, 5'-GCCTCTGCC-
ATCACCCT-3'; both, 5'-CTTGTCGATGAAGGAGG-3'.
Site-Directed Mutagenesis. The EBS-MP point mutation
was engineered in (i) pETK5, a bacterial expression vector
(38), and (ii) pJK5, an SV40 promoter-enhancer-based mam-
malian expression vector (13). All clones were verified by
sequencing the genetically engineered segments.
RESULTS
Diagnosis of EBS-MP Families. EBS 44 is a small family of
German origin, and has been followed clinically by one of us
(J.-D.F.). There is no known prior history of EBS in the family,
but the mother (EBS 44-3) displayed skin blisters predomi-
nantly over her palms and soles (see family tree in Fig. 2).
These blisters appeared at birth and arose in response to mild
physical trauma. Blisters often healed without scarring, and
became less severe with age. At the histological and ultra-
structural level (see below), blisters occurred as a consequence
of basal cell cytolysis. On the basis of these clinical and
ultrastructural features and, in addition, immunofluorescence
antigenic mapping with basal and basal lamina markers
(J.-D.F., unpublished work), a diagnosis ofEBS-WC was made.
In addition, a pigment anomaly was also present at birth. The
trunk and extremities displayed a mosaic pattern of dark and
light pigmented spots (2-5 mm diameter) with irregular bor-
ders. The MP was more prominent in early life, and became
less visible with age. These clinical features were inherited by
one of her sons (EBS 44-6). In addition, the boy, now 12,
continues to develop painful- erosions within the oral cavity,
both buccal mucosa and tongue.
The features seen in EBS 44-6 were similar to those ob-
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FIG. 2. Pedigrees of EBS 44 and SEB1 families. Numbers were
assigned to members for which blood was obtained (skin biopsies in
hyper- and hypopigmented areas were additionally obtained from EBS
44-3, SEBl-41, SEBl-42, and SEBl-44 for the purposes of the present
study). Solid symbols, members clinically affected with EBS; open
symbols, unaffected individuals; cross bar to right, deceased; squares,
males; circles, females.
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described with EBS-MP (see family tree in Fig. 2; ref. 4). This
family originated in Scandinavia and was followed clinically
through four subsequent generations by one of us (T.G.-D.).
Generalized skin blisters appeared at birth in 7 of the 12
affected patients and by early childhood in the remainder of
affected members. Patterns of MP in this family were similar
to those seen in EBS 44-3 and 44-6 and have been described
in detail previously (4). In combination with ultrastructural
analyses showing basal cell cytolysis (see below), a diagnosis of
EBS with MP was made. While both EBS-MP families are
Caucasian and of European origin, there is no known ancestral
relation between them. Moreover, EBS 44-3 is anamnestically
a de novo mutant.
Ultrastructural Analyses. Ultrastructural analyses of EBS
44-3 and of SEB1-41, SEB1-42, and SEB1-44 revealed features
typical of EBS (Fig. 3A). In EBS 44-3, -10% of basal
epidermal cells displayed mild perturbations, including signs of
vacuolization, often adjacent to the nucleus. In the basal layer,
mild abnormalities in keratin cytoarchitecture were consis-
tently observed, including disorganized keratin filaments and
varying degrees of aggregation of keratin filaments (Fig. 3 A
and B, EBS 44-3; Fig. 3C, control; Fig. 3D, SEB1-44). Most
notably was a fine network of seemingly short keratin filaments
in EBS 44-3 basal cells, even in cells displaying no signs of
cytolysis. Intriguingly, some basal and suprabasal cells showed
perinuclear shells of keratin filaments, leaving perinuclear
gaps of as much as 100 nm or more of free cytoplasmic space
with a paucity of organelles (double arrow in Fig. 3B). These
shells are not typical of EBS, but have been described for
ichthyosis hystrix Curth-Macklin type (1, 39) and for transgenic
mice expressing a mutant keratin 10 gene (40). These struc-
tures appeared quite frequently in EBS 44-3 epidermis, but
were infrequent in the three SEB1 patients. In the SEB1-44
sample, the keratin filaments organized in these shells had lost
FIG. 3. Ultrastructure of EBS-MP. (A) Basal cell from the epidermis ofEBS 44-3. Note keratin filaments, atypically in a thin, relatively dispersed
array. Note cytolysis (asterisk) in basal cell at right. (B) Higher magnification of basal cell cytoplasm from EBS 44-3 showing disorganized network
of seemingly short keratin filaments. The EBS 44 basal cells shown inA andB displayed a perinuclear shell of keratin filaments, leaving a gap (double
arrow in B) with a paucity of cytoplasmic organelles. (C) Basal cell cytoplasm from control epidermis showing typical bundles of keratin filaments.
(D) Sample of affected member of SEB1-44, showing initial, subclinical blistering. Note atypical disorganized aggregates of keratin filaments. (E)
Basal and suprabasal epidermal cells from SEB1-44, revealing a cytoplasm densely packed with pigment granules. Nu, nucleus; LD, lamina densa;
kf, keratin filaments; Mi, mitochondria; Me, melanin granules; Hd, hemidesmosome; V, vacuoles. (A, bar = 0.6 ,um in A-D; E, bar = 2.1 Am.)
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FIG. 4. C to T transition at codon 24 in affected family members
of EBS 44. PCR was used to amplify KS sequences from genomic blood
DNAs of all family members of EBS 44. Amplified fragments from two
independent rounds of PCR were subcloned and 12-13 independent
clones were pooled and subjected to DNA sequencing. Note G to A
transition (C to Tin coding strand) at nucleotide 71 (codon 24) in one
of two alleles (arrow). Sequences are from family members indicated
across top. Note, sequences from the DNAs of unaffected members
EBS 44-4 and 44-5 were indistinguishable from those of control
DNAs (see ref. 10).
their desmosome/hemidesmosome contacts, whereas those
cells that maintained these contacts displayed more normal
appearing filament bundles.
There were no signs of clumping of amorphous keratin as is
typical of EBS-DM. The abnormalities in keratin filament
networks preceded cytolysis and blister formation, but increas-
ing aggregation of keratin filaments were formed in areas with
early signs of cytolysis in the SEB1 patients, especially in
SEB1-44 (Fig. 3D). None of the basal cell aberrancies seen in
EBS 44 or SEBi patients were typical of normal skin. Thus,
abnormalities in keratin filament networks existed in both BBS
44 and SEB1 epidermis, even though some variation seemed
to exist between the two families.
In addition to keratin filament anomalies, abnormalities
were seen in melanin granule distribution in BBS 44 and SEB1
epidermis, and this was especially prominent in SEB1-44
(frame B). Heavily loaded, hyperpigmented cells in the basal
and suprabasal layers corresponded in their degree of pigmen-
tation to that seen under conditions of postinflammatory and
postbullous pigmentation. Increased numbers of melanocytes
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were present in both biopsy samples of SEB1-44, while their
frequency was more normal in SEB1-41, SEB1-42, and EBS-
44. Throughout the basal layer of EBS 44-MP skin, mitochon-
dria were frequently clustered within the cytoplasm, an aber-
rancy previously noted for other types ofEBS (Fig. 3A; see also
ref. 11). Thus, the distribution of organelles appeared to be
aberrant in EBS 44 and SEB1 basal epidermal cells, a feature
that is likely to account for the MP seen in these patients.
Affected Members ofEBS 44 and SEB1 Have the Same Point
Mutation Encoding a Pro to Leu Substitution at Codon 24 in
the Nonhelical Head Domain of K5. Given the diagnosis of
EBS and the milder clinical features of EBS 44, we began by
examining the KS alleles of EBS 44-3 to determine whether
mutations in KS might be the source of the genetic defect in
the EBS 44 family. PCRwas used to amplify different segments
of the K5 gene. Only a single point substitution at nucleotide
71 (A of the first ATG = 1; refs. 35 and 37) distinguished one
of the KS alleles from wild-type. The transition caused a
proline (CCG) to leucine (CTG) mutation at codon 24 (Fig. 4).
The PCR/sequencing was reproducible, indicating that the
transition was not due to a polymerase error during PCR. Both
G and A occurred in the sequencing ladder of the noncoding
strand (C and T in the coding strand).
This same nucleotide substitution was also detected in the
affected son, EBS 44-6 (Fig. 4). In contrast, only the wild-type
G residue was detected in the DNAs of the two unaffected
family members, EBS 44-4 and 44-5, analogous to that seen in
control DNAs (35, 37). This confirmed the presence of both
mutant and wild-type sequences in the genomic pool, as
expected of an autosomal dominant disease.
Surprisingly, affected members from SEB1 had DNAs that
were also heterozygous at nucleotide 71 (Fig. 5). This exact
same nucleotide substitution, predicting a P24L mutation in
one of the two KS alleles, was found in affected family
members 22, 32, 33, 34, 36, 41, 42, 44, 46, 51, and 55, and not
in unaffected members 35, 37, 43, 47, 49, 52, and 54 (repre-
sentative examples of these data are shown in Fig. 5). Genomic
DNAs from 50 normal individuals were also homozygous for
the wild-type sequence, verifying that the loss of this site was
not merely reflective of a rare polymorphic variation. When
nucleotide 71 was used as a genetic marker, a combined lod
score at 4 = 0 of 3.9 was obtained for families EBS 44 and
SEB1. This suggested strongly that the genetic lesion in these

































FIG. 5. C to T transition at codon 24 in affected family members of SEB1. PCR was used to amplify K5 sequences from genomic blood DNAs
of the following SEB1 family members: 22, 32-37, 41-44, 46, 47, 49, 51, 52, 54, and 55 (see Fig. 2). Amplified fragments from two independent
rounds of PCR were subcloned and 12-13 independent clones were pooled and subjected to DNA sequencing. Note G to A transition (C to T in
coding strand) at nucleotide 71 (codon 24) in one of two alleles (arrow). Representative sequences are from family members indicated across top.
Note, the heterozygous mutation found in SEB1-22 and SEB1-51 was present in DNAs of all affected family members, while unaffected members,
including SEB1-37, SEB1-47, SEB1-52, and SEB1-54, had the wild-type nucleotide 71.
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families resided within the keratin loci on chromosome 12q11-
q13, specifically, within the K5 gene.
Sequencing of the EBS 44-3 KS cDNA did not uncover any
additional mutations. Discrepancies existed between our se-
quence and published K5 sequences (35, 37), but not with the
sequence reported by Chan et al. (10). In addition to a KS
polymorphism previously described (196E/D GAA/GAC; ref.
10), we found three silent polymorphisms (116L/L CTC/CTT;
197T/T ACA/ACC; and 243L/L CTG/CTA). Other poly-
morphisms in the variable head and tail domains of other
keratins have been described (41, 42).
The P24L Mutation Does Not Markedly Affect the Assembly of
Keratin Filament Networks In Transfected Cultured Cells Nor
the Assembly of Keratin Filaments in Vitro. Given that PtK2 cells
have a keratin network that is more sensitive to subtle perturba-
tions than epidermal keratinocytes (13), we used these cells to test
for the effects of the P24L K5 mutation on filament network
formation. The majority of PtK2 cells transfected with the P24L
K5 expression vector showed a typical keratin network, indistin-
guishable from wild-type (Fig. 6A; see ref. 13 for examples of
wild-type cells). Some of the cells contained a collapsed keratin
network (Fig. 6B), but the percentage of these brightly anti-P
stained cells was comparable to those seen in cells transfected
with the wild-type K5 counterpart, and likely arise from transgene
overexpression in some cells (see ref. 14).
We also examined the ability of bacterially expressed P24L K5
to assemble into keratin filaments when combined with wild-type
K14 in vitro. Under the conditions used, wild-type K5 and K14
assembled into long 10 nm filaments (Fig. 6C). P24L K5 and K14
also assembled into 10 nm filaments, but there were some
reproducible differences in their overall length and uniformity
(Fig. 6D). Most notably, the mutant K5-containing filaments
were -18% shorter than wild-type filaments (mutant, 1.12 gm
mean length, 0.56 standard deviation; wild-type, 1.36 ,um mean
length, 0.42 standard deviation). No differences were seen in
polymerization efficiency as judged by a filament centrifugation
assay (data not shown; ref. 38). Thus, it seems that either (i) the
mutation slightly enhances the nucleation offilament assembly, so
that there are more assembled filaments with an overall shorter
length, or (ii) the mutation slightly impairs the rate of elongation
or the stability of the assembled filaments at steady state, leading
to shorter filaments. These results were consistent with the
ultrastructural data on EBS 44, revealing an overall shortened
appearance to the keratin filaments in basal cells.
DISCUSSION
A number of lines of evidence indicate that the C to T
transition at nucleotide 71 of human KS underlies the genetic
basis for EBS in families 44 and SEBl: (i) the mutation was not
found in 100 wild-type alleles; (ii) the mutation was carried
only by affected family members; (iii) the mutation was
inherited in an autosomal dominant fashion, characteristic of
the pattern of inheritance in these families; (iv) the peak
logarithm of odds score at 4 = 0 was 3.9 for this mutation; and
(v) point mutations in K5 and its partner K14 are known to
account for all of the EBS cases reported thus far, and are
therefore likely to account for the majority of EBS in the
population (refs. 7-12, 25, and 34, and references therein).
Interestingly, another family with EBS-MP was previously
found to have a defect(s) mapping to chromosome 12, near or
at the location of the KS gene (45). However, after not
detecting any mutation in the rod domains of keratins 5 and 14,
these researchers erroneously concluded that EBS-MP is not
a disorder of keratins 5 and 14 (45).
Residue 24 of KS occurs early within the amino terminal
head (Fig. 1), in a region that is not known to appreciably affect
10 nm filament assembly (17, 29). Moreover, the sequences
within the amino half of the head domain are not highly
evolutionarily conserved, even among the type II keratins
(residue 24 is proline, however, in all K6 isoforms; ref. 46). Our
FIG. 6. Filament network formation and filament assembly are not
appreciably affected in in vitro assays of the P24L mutation. (A and B)
Transient transfections. Potoroo kidney epithelial (PtK2) cells were
transiently transfected with epitope (neuropeptide substance P-
tagged), wild-type, or mutant K5 cDNAs driven by the SV40 major
early promoter and enhancer (13, 14). At 65 hr posttransfection, cells
were fixed and examined by indirect double immunofluorescence,
using a rabbit anti-P antiserum to recognize the neuropeptide sub-
stance P tag and an anti-K8 antibody (LE41) to recognize the
endogenous keratin network. Shown are representative examples of
cells transfected with the P24L K5 mutant and stained with anti-P.
Data were indistinguishable from those obtained with wild-type KS
(data not shown; see ref. 13 for examples). The majority of the
transfected cells displayed a wild-type network as shown in A. Ap-
proximately 13% of the transfected cells displayed a collapsed network
as shown in B. (C and D) In vitro filament assembly studies. Wild-type
K5 (C) and P24L K5 (D) were combined with wild-type K14 at a
concentration of300 ,ug/ml, and dialyzed against 3 mM Tris HCI (pH 7.2)
and 5 mM 2-mercaptoethanol (38,43). Assembled filaments were diluted
1:10 in 3 mM Tris-HCl (pH 7.2) before negative staining and electron
microscopy. Filament lengths were recorded from computer scanned
negatives using the IMAGE software (National Institutes of Health, Be-
thesda). Assembled filaments from two separate experiments were ana-
lyzed, with comparable results. Note, a fraction ofthe assembled filaments
was also subjected to centrifugation at 100,000 x g for 40 min at 4°C; both
mutant and wild-type preparations yielded comparable amounts of
keratin in the pellet fraction, indicating that the mutation does not impair
the efficiency with which the protein polymerizes into filaments in vitro.
(A and B, bar = 10 gm; C and D, bar = 200 nm.)
filament network and in vitro assembly studies with P24L K5
demonstrate that this mutation does not grossly change the
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conformation of the head domain in a fashion that is incom-
patible with filament assembly, but that it does modestly affect
the overall length and uniformity of the filaments. Thus,
despite its position within the keratin polypeptide, the P24L
mutation appears able to in part account for the perturbations
seen in the basal keratin networks in EBS 44 and SEB1 families
and for the fragility of these cells to mechanical stress.
We have not examined the possibility that polymorphic
variations, either in the K5 and K14 themselves or in other
associating proteins, might be responsible for the differences
that exist in the keratin filament architectures within the two
families. Interestingly, however, both families showed aberra-
tions in the degree of the lateral association of keratin fila-
ments into bundles, and both families displayed alterations in
the overall keratin cytoskeletal network.
A striking and consistent feature of the two EBS-MP
families was the variability in melanin granule distribution. A
priori the high degree of subclinical blister formation in the
EBS 44 and SEB1 patients together with signs of subsequent
repair suggest the possibility that hyperpigmentation may arise
from postbullous pigmentation. This notion is supported by a
focal increase in the number of melanocytes in the SEB1-44
biopsies (data not shown). This said, all EBS subtypes are
typified by basal cell cytolysis and tissue repair, and yet only a
small fraction of these have been characterized as having EBS
with MP. While we cannot unequivocally rule out the possi-
bility that the MP arises from a second albeit closely linked
gene defect, this seems unlikely. Rather, given that two
seemingly unrelated EBS-MP families have the exact same
keratin mutation, it is likely that this single mutation generates
MP as well as EBS.
How might the P24L K5 mutation affect pigmentation in
basal cells? Based on proteolysis experiments, it is likely that
residue 24 is in a region that at least in part protrudes along the
filament surface (47). Thus, the P24L KS mutation could
interfere with the association between keratin filaments and
other elements in the basal cell cytoplasm. Based on our
present studies, it seems most likely that the keratin defect
causes a subtle perturbation in keratin cytoarchitecture that
may influence either longevity of melanin granules in basal
cells or alternatively the efficiency of melanin granule transfer
from melanocytes. Alternatively, a perturbation in the asso-
ciation between the KS head domain and desmosomes and/or
hemidesmosomes (48) could contribute to cytolysis somewhat
differently than defects in filament assembly, resulting in
continual subclinical blistering and variability in epidermal
pigmentation.
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